Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (347419)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website Save this grant

Next deadline: May 20, 2024 (Letter of inquiry)

Later deadlines: Jun 20, 2024 (Full proposal), Aug 7, 2024 (Letter of inquiry), Sep 7, 2024 (Full proposal), Sep 9, 2024 (Letter of inquiry), Oct 9, 2024 (Full proposal), Dec 7, 2024 (Letter of inquiry), Dec 7, 2024 (Letter of inquiry), Jan 7, 2025 (Full proposal), Feb 13, 2025 (Letter of inquiry), Mar 13, 2025 (Full proposal), Apr 7, 2025 (Letter of inquiry), May 7, 2025 (Full proposal), May 20, 2025 (Letter of inquiry), Jun 20, 2025 (Full proposal), Aug 25, 2025 (Letter of inquiry), Sep 7, 2025 (Full proposal), Sep 9, 2025 (Letter of inquiry), Oct 9, 2025 (Full proposal), Jan 7, 2026 (Full proposal), Feb 13, 2026 (Letter of inquiry), Mar 13, 2026 (Full proposal), Apr 7, 2026 (Letter of inquiry), May 7, 2026 (Full proposal), Dec 7, 2026 (Letter of inquiry)

Grant amount: Up to US $500,000

Fields of work: Neuroscience Addiction & Substance Use Disorders

Applicant type: Nonprofit, Government Entity, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: The following deadlines apply to standard grant applications (due by 5:00 pm  local time of applicant organization):

* June 21, 2023
* October 9, 2023
* March 13, 2024
* June 20, 2024
* October 9, 2024
* March 13, 2025
* June 20, 2025
* October 9, 2025
* March 13, 2026

The following deadlines apply to AIDS-related grant applications (due by 5:00 pm local time of applicant organization): 
* September 7, 2023
* January 7, 2024
* May 7, 2024
* September 7, 2024
* January 7, 2025
* May 7, 2025
* September 7, 2025
* January 7, 2026
* May 7, 2026

This Funding Opportunity Announcement (FOA) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying SUD, including fundamental brain function relevant to substance use. This FOA is particularly designed to support exploratory/developmental projects requiring budgets that would exceed that allowed for the R21 mechanism (Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

US Dept. of Health & Human Services: National Institutes of Health (NIH)
FUNDER

Your history with this funder
0
SAVED OPPORTUNITIES
No saved opportunities from this funder yet
FUNDER NOTES
Save this opportunity to add notes...
CONTACTS
Save this opportunity to add contacts...

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

Find funders like US Dept. of Health & Human Services: National Institutes of Health (NIH)

See funders proven to support nonprofits like yours.

No credit card required.
instrumentl testimonial face

"Winning 30% more grants thanks to Instrumentl was a huge morale boost. My confidence continues to grow."

Linda Rucker, Grant Writer

This page was last reviewed April 12, 2023 and last updated April 12, 2023